'''First Phase III results from the clinical development program QUANTI on investigational MRI contrast agent gadoquatrane presented as late-breaking data during a scientific session at the ...'
Wednesday, 26 February 2025 by https://www.bayer.com
'''Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an investigational gadolinium-based contrast agent (GBCA) for use ...'
Friday, 10 January 2025 by https://www.itnonline.com
'''Ultra-small gadolinium oxide nanoparticles (Gd2O3) are being developed as positivecontrast agents for molecular and cellular magnetic resonance imaging (MRI). Recent studies have demonstrated that these particles can be used to label and track cells in ...'
I don't think there's anything unique about human intellience. All the nuerons
in the brain that make up perceptions and emotions operate in a binary fashion. -
Bill Gates